Moreover, miR‐635 was shown to inhibit the tumorigenesis of NSCLC by targeting YY1.19 However, in the present study, JAK1 and JAK3 were characterized as the potential targets of miR‐635 by means of dual‐luciferase reporter assay. This evidence concerns the gene JAK3 and non-small cell lung carcinoma.